loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X

List of chemical intermediates, fine chemicals supplied/manufactured by Estechpharma

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 (S)-1,2,3,4-tetrahydro-1-phenylisoquinoline (1)

02 2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethyl methanesulfonate (1)

03 2-Amino-3-pyridinemethanol (1)

04 3-(4-methyl-1H-imidazol-1-yl)-5-trifluoromethylbenzenamine (1)

05 4,5,6,7-tetrahydro-1H-benzo[d]imidazole-5-carboxylic acid hydrochloride (1)

06 4- [(1- methylethyl) amino] -1- Butanol (1)

07 4-(2-hydroxyethyl)indolin-2-one (1)

08 4-(4-Fluorophenyl)-5,6,7,8,9,10-hexahydrocyclo-octa[b]pyridin-2(1H)-one (1)

09 4-(N-isopropyl-N-(5,6-diphenylpyrazin-2-yl)amino)butan-1-ol (1)

10 5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile (2R,3R)-2,3-dihydroxybutanedioate (1)

11 Ethyl 3-(2-((4-cyanophenylamino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrobromide (1)

filter

01 Blonanserin (1)

02 Dabigatran Etexilate Mesylate (1)

03 Mirtazapine (1)

04 Nilotinib (1)

05 Ramosetron (1)

06 Ropinirole (1)

07 Selexipag (2)

08 Silodosin (2)

09 Solifenacin Succinate (1)

filter

01 1046806-03-4 (1)

02 118864-75-8 (1)

03 131020-57-0 (1)

04 132812-72-7 (1)

05 139122-19-3 (1)

06 160969-03-9 (1)

07 23612-57-9 (1)

08 239463-85-5 (1)

09 42042-71-7 (1)

10 475086-75-0 (1)

11 641571-11-1 (1)

URL Supplier Web Content
118864-75-8
Solifenacin Succinate
ESTECHPHARMA CO.,LTD., as one of the active pharmaceutical company, is remarkably growing more than ...
ESTECHPHARMA CO.,LTD., as one of the active pharmaceutical company, is remarkably growing more than 30% every year by concentrating all our efforts into developing new technologies by investing more than 15% of the annual turnover into R&D since our foundation in 1996. That is company ideology, challenge and creation. We've succeeded in synthesizing 40 kinds of APIs like Anti-inflammatory medicine, Anti-ulcerants, Anti-hepatitis, Treatments of Alcoholism, and etc secondly or thirdly in the world or firstly in Korea, and have been producing and supplying continuously to our customers.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
160969-03-9
Silodosin
ESTECHPHARMA CO.,LTD., as one of the active pharmaceutical company, is remarkably growing more than ...
ESTECHPHARMA CO.,LTD., as one of the active pharmaceutical company, is remarkably growing more than 30% every year by concentrating all our efforts into developing new technologies by investing more than 15% of the annual turnover into R&D since our foundation in 1996. That is company ideology, challenge and creation. We've succeeded in synthesizing 40 kinds of APIs like Anti-inflammatory medicine, Anti-ulcerants, Anti-hepatitis, Treatments of Alcoholism, and etc secondly or thirdly in the world or firstly in Korea, and have been producing and supplying continuously to our customers.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
23612-57-9
Mirtazapine
ESTECHPHARMA CO.,LTD., as one of the active pharmaceutical company, is remarkably growing more than ...
ESTECHPHARMA CO.,LTD., as one of the active pharmaceutical company, is remarkably growing more than 30% every year by concentrating all our efforts into developing new technologies by investing more than 15% of the annual turnover into R&D since our foundation in 1996. That is company ideology, challenge and creation. We've succeeded in synthesizing 40 kinds of APIs like Anti-inflammatory medicine, Anti-ulcerants, Anti-hepatitis, Treatments of Alcoholism, and etc secondly or thirdly in the world or firstly in Korea, and have been producing and supplying continuously to our customers.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
641571-11-1
Nilotinib
ESTECHPHARMA CO.,LTD., as one of the active pharmaceutical company, is remarkably growing more than ...
ESTECHPHARMA CO.,LTD., as one of the active pharmaceutical company, is remarkably growing more than 30% every year by concentrating all our efforts into developing new technologies by investing more than 15% of the annual turnover into R&D since our foundation in 1996. That is company ideology, challenge and creation. We've succeeded in synthesizing 40 kinds of APIs like Anti-inflammatory medicine, Anti-ulcerants, Anti-hepatitis, Treatments of Alcoholism, and etc secondly or thirdly in the world or firstly in Korea, and have been producing and supplying continuously to our customers.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
131020-57-0
Ramosetron
ESTECHPHARMA CO.,LTD., as one of the active pharmaceutical company, is remarkably growing more than ...
ESTECHPHARMA CO.,LTD., as one of the active pharmaceutical company, is remarkably growing more than 30% every year by concentrating all our efforts into developing new technologies by investing more than 15% of the annual turnover into R&D since our foundation in 1996. That is company ideology, challenge and creation. We've succeeded in synthesizing 40 kinds of APIs like Anti-inflammatory medicine, Anti-ulcerants, Anti-hepatitis, Treatments of Alcoholism, and etc secondly or thirdly in the world or firstly in Korea, and have been producing and supplying continuously to our customers.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
42042-71-7
Selexipag
ESTECHPHARMA CO.,LTD., as one of the active pharmaceutical company, is remarkably growing more than ...
ESTECHPHARMA CO.,LTD., as one of the active pharmaceutical company, is remarkably growing more than 30% every year by concentrating all our efforts into developing new technologies by investing more than 15% of the annual turnover into R&D since our foundation in 1996. That is company ideology, challenge and creation. We've succeeded in synthesizing 40 kinds of APIs like Anti-inflammatory medicine, Anti-ulcerants, Anti-hepatitis, Treatments of Alcoholism, and etc secondly or thirdly in the world or firstly in Korea, and have been producing and supplying continuously to our customers.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
139122-19-3
Ropinirole
ESTECHPHARMA CO.,LTD., as one of the active pharmaceutical company, is remarkably growing more than ...
ESTECHPHARMA CO.,LTD., as one of the active pharmaceutical company, is remarkably growing more than 30% every year by concentrating all our efforts into developing new technologies by investing more than 15% of the annual turnover into R&D since our foundation in 1996. That is company ideology, challenge and creation. We've succeeded in synthesizing 40 kinds of APIs like Anti-inflammatory medicine, Anti-ulcerants, Anti-hepatitis, Treatments of Alcoholism, and etc secondly or thirdly in the world or firstly in Korea, and have been producing and supplying continuously to our customers.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
132812-72-7
Blonanserin
ESTECHPHARMA CO.,LTD., as one of the active pharmaceutical company, is remarkably growing more than ...
ESTECHPHARMA CO.,LTD., as one of the active pharmaceutical company, is remarkably growing more than 30% every year by concentrating all our efforts into developing new technologies by investing more than 15% of the annual turnover into R&D since our foundation in 1996. That is company ideology, challenge and creation. We've succeeded in synthesizing 40 kinds of APIs like Anti-inflammatory medicine, Anti-ulcerants, Anti-hepatitis, Treatments of Alcoholism, and etc secondly or thirdly in the world or firstly in Korea, and have been producing and supplying continuously to our customers.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
475086-75-0
Selexipag
ESTECHPHARMA CO.,LTD., as one of the active pharmaceutical company, is remarkably growing more than ...
ESTECHPHARMA CO.,LTD., as one of the active pharmaceutical company, is remarkably growing more than 30% every year by concentrating all our efforts into developing new technologies by investing more than 15% of the annual turnover into R&D since our foundation in 1996. That is company ideology, challenge and creation. We've succeeded in synthesizing 40 kinds of APIs like Anti-inflammatory medicine, Anti-ulcerants, Anti-hepatitis, Treatments of Alcoholism, and etc secondly or thirdly in the world or firstly in Korea, and have been producing and supplying continuously to our customers.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
239463-85-5
Silodosin
ESTECHPHARMA CO.,LTD., as one of the active pharmaceutical company, is remarkably growing more than ...
ESTECHPHARMA CO.,LTD., as one of the active pharmaceutical company, is remarkably growing more than 30% every year by concentrating all our efforts into developing new technologies by investing more than 15% of the annual turnover into R&D since our foundation in 1996. That is company ideology, challenge and creation. We've succeeded in synthesizing 40 kinds of APIs like Anti-inflammatory medicine, Anti-ulcerants, Anti-hepatitis, Treatments of Alcoholism, and etc secondly or thirdly in the world or firstly in Korea, and have been producing and supplying continuously to our customers.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY